603811.SHG · Zhejiang Cheng Yi Pharmaceutical Co., Ltd

-

Please sign in to comment on 603811.SHG

1 Comment

Admin

4 years, 1 month ago

Zhejiang Cheng Yi Pharmaceutical Co., Ltd is currently in a long term uptrend where the price is trading 2.0% above its 200 day moving average.

From a valuation standpoint, the stock is 21.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 7.6.

Zhejiang Cheng Yi Pharmaceutical Co., Ltd's total revenue rose by 13.7% to $182M since the same quarter in the previous year.

Its net income has increased by 27.8% to $39M since the same quarter in the previous year.

Finally, its free cash flow fell by 133.6% to $-10M since the same quarter in the previous year.

Based on the above factors, Zhejiang Cheng Yi Pharmaceutical Co., Ltd gets an overall score of 4/5.

CurrencyCode	CNY
ISIN	CNE100002YC7
Exchange	SHG
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic

PE Ratio	13.75
Target Price	None
Market Cap	3B
Beta	0.41
Dividend Yield	None

ABOUT

Zhejiang Cheng Yi Pharmaceutical Co., Ltd

Zhejiang Cheng Yi Pharmaceutical Co., Ltd. produces and sells APIs, injections, capsules, tablets, pharmaceutical intermediates in China. The company was formerly known as Wenzhou No. 3 Pharmaceutical Factory and changed its name to Zhejiang Cheng Yi Pharmaceutical Co., Ltd. in April 2001. Zhejiang Cheng Yi Pharmaceutical Co., Ltd. was founded in 1966 and is headquartered in Shanghai, China.

603811.SHG · Zhejiang Cheng Yi Pharmaceutical Co., Ltd

-

Zhejiang Cheng Yi Pharmaceutical Co., Ltd

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Zhejiang Cheng Yi Pharmaceutical Co., Ltd using a moving average strategy